Your browser doesn't support javascript.
loading
Lanreotide Depot: An Antineoplastic Treatment of Carcinoid or Neuroendocrine Tumors.
Wolin, Edward M; Manon, Amandine; Chassaing, Christophe; Lewis, Andy; Bertocchi, Laurent; Richard, Joel; Phan, Alexandria T.
Afiliação
  • Wolin EM; Medical Oncology, Montifiore Einstein Center for Cancer Care, 1695 Eastchester Rd., Second Floor, Bronx, NY, 10461, USA. ewolin@montefiore.org.
  • Manon A; Clinical Pharmacokinetics and Drug Metabolism, Ipsen Innovation, 5 Avenue du Canada, 91140, Les Ulis, France.
  • Chassaing C; Peptide Development, Beaufour Ipsen Industrie, Rue Ethe Virton, 28109, Dreux, France.
  • Lewis A; Peptide Development, Beaufour Ipsen Industrie, Rue Ethe Virton, 28109, Dreux, France.
  • Bertocchi L; Peptide Development, Beaufour Ipsen Industrie, Rue Ethe Virton, 28109, Dreux, France.
  • Richard J; Peptide Development, Beaufour Ipsen Industrie, Rue Ethe Virton, 28109, Dreux, France.
  • Phan AT; Houston Methodist Hospital, 6410 Fannin St, Houston, TX, 77030, USA.
J Gastrointest Cancer ; 47(4): 366-374, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27619395
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Somatostatina / Tumor Carcinoide / Carcinoma Neuroendócrino / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Somatostatina / Tumor Carcinoide / Carcinoma Neuroendócrino / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article